Navigation

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director m
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director mRNA Value Chain, Synthesis & ADC, Merck Life Science Services and MD AmpTec GmbH and Tanja Stadie, Head Of Quality, Merck Group/AmpTec GmbH at the official opening of the new mRNA production facility in Hamburg. (from left - Image: Merck KGaA)

Merck/AmpTec: New mRNA manufacturing site opened in Hamburg

Merck, a leading science and technology company, today became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical ...

Read more …
Peter Scheinert, Founder & CEO of Amptec GmbH

Facing the Challenge >> AmpTec

AmpTec is an internationally leading provider of RNA technology products, including RNA isolation and mRNA amplification kits, synthetic long RNAs and DNAs ...

Read more …

EURM-019 for quality control of SARS-CoV-2 detection

The European Commission has announced the release of a universal COVID-19 positive control IVT RNA called EURM-019 to facilitate the quality control of the ...

Read more …
Job board